No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Piper Sandler Initiates Blueprint Medicines(BPMC.US) With Hold Rating, Announces Target Price $119
Wolfe Research Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $132
Director's Major Stock Sale Shakes Up Blueprint Medicines!
Blueprint Medicines Initiated With an Outperform at Wolfe Research
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
